Summit Therapeutics SMMT Ratios (2014-2026)

NASDAQ SMMT
$16.94 -0.89 (-4.96%)
As of: Nov 11, 2026 · 11:40 AM EST
Reported Financials

Summit Therapeutics Quarterly Ratios

Periods 51 quarters
Latest Sep 2026

Summit Therapeutics ratios data for the quarter ended Sep 2026. These financial ratios cover 51 quarters of results from Apr 2014 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Apr2014 Jul2014 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Dec2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Mar2019 Jul2019 Sep2019 Oct2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Profitability
Gross Margin
EBT Margin
-10,796.41%-8,863.20%-5,400.85%-7,700.00%
EBIT Margin
-10,377.29%-8,863.20%-5,400.85%-7,700.00%
EBITDA Margin
-10,246.61%-8,736.40%-5,260.00%-7,559.09%
Operating Margin
-10,377.29%-8,863.20%-5,400.85%-7,700.00%
Net Margin
-10,796.41%-8,558.80%-7,136.60%-9,720.45%
FCF Margin
-3,704.78%-7,744.80%-8,302.13%-3,879.55%
Efficiency
Assets AverageAssets Avg.
121.02M114.92M106.10M125.52M409.75M459.53M246.13M227.92M210.71M189.87M259.32M422.35M469.21M409.69M353.93M292.88M506.46M699.52M700.02M722.52M
Equity AverageEquity Avg.
92.79M73.85M57.86M92.28M129.95M130.07M126.54M109.49M88.54M60.95M119.64M316.50M413.33M366.54M301.88M225.85M425.56M602.40M587.96M597.33M
Invested CapitalInvested Cap.
83.28M89.46M76.63M640.96M233.48M219.60M199.38M177.69M144.21M295.08M462.42M388.75M
Asset Utilization RatioAsset Util.
0.010.020.020.010.000.000.00
Leverage & Solvency
Interest Coverage RatioInterest Cover
-13.58-19.22-23.79-0.01M
Debt Ratio
0.220.260.770.390.420.460.490.570.290.05
Times Interest Earned
-13.58-19.22-23.79-0.01M
Valuation
Price to EarningsP/E
Price to SalesP/S
145.79128.7647.98184.950.00M0.00M0.01M
Price to BookP/B
3.173.731.911.337.084.9614.6413.1323.5765.7428.9636.8633.8541.5560.9380.0020.5826.9518.3423.95
Enterprise Value
191.94M162.95M40.79M54.84M548.53M419.85M1,536.18M1,106.04M1,645.09M2,749.49M5,324.23M15,655.48M12,746.90M13,944.33M15,509.05M15,141.63M12,847.79M14,114.56M10,865.09M12,893.59M
EV to EBIT
Market Capitalization
263.73M240.40M98.12M176.81M897.14M661.79M1,751.19M1,304.98M1,831.33M2,906.17M5,649.70M16,142.38M13,159.25M14,305.65M15,806.93M15,380.18M13,561.24M14,713.29M11,555.76M13,523.37M
Price to FCFP/FCF
EV to FCF
EV to CFO
Return Ratios
Return on Sales [ROS]ROS
-10,377.29%-8,863.20%-5,400.85%-7,700.00%-10,225.39%-129,029.67%-268,266.82%
Return on Capital Employed [ROCE]ROCE
-90.34%-99.16%-88.41%-71.51%-19.43%-132.80%-252.00%-519.99%-320.35%-69.03%-133.20%-54.11%-52.87%
Return on Invested Capital [ROIC]ROIC
Return on Assets [ROA]ROA
-71.89%-81.23%-80.55%-68.85%-19.15%-129.96%-242.54%-261.80%-292.10%-61.66%-62.34%-46.54%-47.11%-58.77%-210.87%-314.81%-213.22%-172.43%-122.28%-115.25%
Return on Equity [ROE]ROE
-93.76%-126.41%-147.69%-93.65%-60.39%-459.14%-471.77%-544.98%-695.18%-192.09%-135.12%-62.11%-53.48%-65.69%-247.22%-408.24%-253.74%-200.23%-145.59%-139.40%

Summit Therapeutics Ratios API

Pull Summit Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SMMT&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY